相关实验视频
Updated: Sep 17, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Rab27a+CAF外体miR-9-5p通过CREBRF/MAPK信号通路促进骨髓瘤的进展
Xiaoying Niu1, Wen Tian2, Zhongyi Li3
1Bone and Soft tissue department, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
与癌症相关的纤维细胞 (CAFs) 释放含有miR-9-5p的外体,通过激活MAPK通路并降低CREBRF.p的调节,驱动骨肉瘤进展和化学抵抗. 这突出了外体miR-9-5p作为潜在的生物标志物和骨髓瘤的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 骨髓瘤是一种常见的青少年骨癌,复发率高,化学抵抗性强.
- 外体细胞调解细胞间通信,是潜在的癌症生物标志物/治疗药物.
- 在骨髓瘤进展中CAF外体miRNA的机制尚未完全理解.
研究的目的:
- 研究Rab27a+CAFs外体miR-9-5p在骨髓瘤恶性瘤中的作用.
- 阐明CREBRF/MAPK信号轴参与的情况.
- 确定外体miR-9-5p作为潜在的生物标志物和治疗点.
主要方法:
- 从血清/组织中分离出外体,小RNA测序,对miR-9-5p进行qRT-PCR.
- 单细胞RNA测序用于瘤微环境的表征.
- 双露西法酶测定,体外/体内功能测定 (CCK8,Edu,细胞周期,细胞亡,小鼠模型).
主要成果:
- 外体miR-9-5p在骨髓瘤患者中升高调节,并与预后不佳有关.
- 确定Rab27a+CAFs是瘤微环境中的关键贡献者.
- 外体miR-9-5p通过向CREBRF和激活MAPK信号,促进了骨髓瘤的扩散,对西斯普拉丁的耐药性,细胞周期的进展,并抑制了细胞亡.
结论:
- 拉布27a+CAF外体miR-9-5p促进骨髓瘤的进展和化学抵抗.
- 该机制涉及CREBRF抑制和MAPK通路激活.
- 外体 miR-9-5p 是一个有前途的生物标志物和治疗目标,用于骨髓瘤精度治疗.
更多相关视频
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
MAPK Signaling Cascades
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Induced Pluripotent Stem Cells
Somatic...